Potential new colorectal cancer treatment target identified

October 7, 2012
Potential new colorectal cancer treatment target identified
The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research published online Oct. 1 in Cancer.

(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research published online Oct. 1 in Cancer.

Marica Gemei, Ph.D., of CEINGE-Advanced Biotechnology in Naples, Italy, and colleagues characterized CD66c expression in colorectal cancer stem cells by and immunohistochemistry in colon cancer samples and normal tissue. They evaluated its expression in colon cancer stem cells and in stem cell-enriched colon spheres and examined the role of RNA-mediated CD66c silencing on the in vitro and in vivo growth of Caco2 .

Compared with normal colon tissues, the researchers found that CD66c expression was significantly higher in colorectal cancer samples, with expression correlating with cancer stage. Its expression was absent in Prominin 1 (CD133)-positive cells from normal colon but was brightest (CD66cbright) in CD133-positive colon cancer samples. In vitro experiments in stem cell-enriched colon spheres exhibited cells expressing CD66cbright, similar to that observed in fresh . In Caco2 cells, CD66c silencing hampered in vitro proliferation and clonogenic potential, and in vivo xenograft experimentation attenuated the tumorigenic potential of Caco2 cells.

"CD66cbright expression was associated with colon cancer stem cells and CD66c silencing blocked tumor growth, thereby opening the way to a potential new treatment for colon cancer," the authors write.

Explore further: Whole grape - seed and skin - may be perfect colon cancer fighting food

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Researchers develop method to map cancer progression

June 27, 2016

A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies.

NASA technology applied in breast cancer study

June 27, 2016

Getting spacecraft ready for launch may have more to do with medical research than you think. For a new study on microbes that may be associated with a history of breast cancer, researchers at NASA's Jet Propulsion Laboratory, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.